nipradilol has been researched along with Coronary Disease in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (66.67) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, T; Fujita, S; Hayakawa, H; Kaneko, H; Kiuchi, K; Nejima, J; Sato, N; Suzuki, Y | 1 |
Hibi, N; Iida, K; Itoh, K; Iyeda, N; Kakinuma, Y; Kobayashi, S; Matsubara, T; Miyajima, K; Nishida, T; Okamoto, Y | 1 |
Abiko, Y; Chiba, K; Hayase, N; Ichihara, K; Inagaki, S | 1 |
Higuchi, M | 1 |
Haneda, T; Ichihara, K; Onodera, S | 1 |
Abiko, Y; Chiba, K; Hayase, N; Hino, T; Hiro, T; Ichihara, K | 1 |
Hieda, N; Ito, T; Ogawa, T; Ozawa, T; Satake, T; Sugiyama, S | 1 |
Noguchi, K; Sakanashi, M | 1 |
Asakawa, T; Higuchi, M | 1 |
9 other study(ies) available for nipradilol and Coronary Disease
Article | Year |
---|---|
[Regional myocardial blood flow measurement with radioactive microspheres in dogs with myocardial ischemia].
Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Coronary Disease; Dogs; Female; Male; Microspheres; Propanolamines | 1991 |
Beneficial effect of nipradilol (K-351) on acute myocardial ischemia. Study of the relationship between regional myocardial blood flow and energy metabolism.
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Energy Metabolism; Heart; Heart Rate; In Vitro Techniques; Mitochondria, Heart; Myocardium; Oxygen Consumption; Phosphocreatine; Propanolamines | 1990 |
Effect of nipradilol on myocardial energy metabolism in the dog ischaemic heart.
Topics: Adenine Nucleotides; Adrenergic beta-Antagonists; Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Energy Metabolism; Female; Heart; Heart Rate; Lactates; Male; Myocardium; Phosphocreatine; Propanolamines | 1990 |
Participation of the vasodilating property of nipradilol in improving ischemic derangement of myocardial energy metabolism.
Topics: Animals; Blood Pressure; Cardiac Output; Coronary Disease; Coronary Vessels; Dogs; Energy Metabolism; Heart; Heart Rate; Lactates; Male; Myocardium; Phosphates; Phosphocreatine; Propanolamines; Propranolol; Vasodilator Agents | 1989 |
Effects of nicorandil and nipradilol on ischemic myocardium in perfused rat heart.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Heart; In Vitro Techniques; Lactates; Male; Niacinamide; Nicorandil; Phosphocreatine; Propanolamines; Rats; Rats, Inbred Strains | 1989 |
Nipradilol, a beta-adrenoceptor antagonist having a vasodilatory action, attenuates myocardial acidosis induced by coronary artery occlusion in dogs.
Topics: Acidosis; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Pacing, Artificial; Coronary Disease; Coronary Vessels; Dogs; Electrocardiography; Female; Heart Rate; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Myocardium; Propanolamines; Vasodilator Agents | 1989 |
Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
Topics: Acetylglucosaminidase; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Bisoprolol; Coronary Circulation; Coronary Disease; Dogs; Female; Glucuronidase; Heart Failure; Heart Rate; Lysosomes; Male; Mitochondria, Heart; Myocardial Contraction; Myocardial Infarction; Propanolamines; Propranolol; Ventricular Fibrillation | 1989 |
Effects of nipradilol on myocardial ischaemia produced by coronary stenosis in dogs.
Topics: Adrenergic alpha-Antagonists; Animals; Cardiac Pacing, Artificial; Coronary Disease; Dogs; Female; Hemodynamics; Lactates; Lactic Acid; Male; Myocardium; Propanolamines; Propranolol | 1987 |
Effects of nipradilol, a new beta-adrenoceptor blocking agent with vasodilating properties, on transmural energy metabolism in the underperfused canine heart.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Disease; Dogs; Energy Metabolism; Heart; Hemodynamics; Lactates; Male; Myocardial Contraction; Myocardium; Phosphates; Propanolamines; Vasodilator Agents | 1987 |